Lupin opens Inhalation Research center in Florida

Wednesday, August 12, 2015

Mumbai-based pharmaceutical company Lupin has opened a new Center of Excellence for Inhalation Research in Coral Springs, Fla. Lupin’s new facility will focus on the R&D of inhalation products for asthma, allergic rhinitis, chronic obstructive pulmonary diseases and other lung diseases.

[Read More]

Lilly expects original drugs sales to triple in India

Friday, September 16, 2011

American drug maker Eli Lilly will bet on its original drugs as it aims to triple sales in India over the next five years. Unlike other foreign drug makers, it plans to stay away from acquisition of local firms or branded generics to boost its market share, according to The Economic Times.

[Read More]

Salix expands partnership with Lupin

Friday, April 8, 2011

Morrisville, North Carolina-based Salix Pharmaceuticals licensed a drug delivery technology from Mumbai, India-based Lupin Pharmaceuticals in 2009. Salix uses that technology in its gastrointestinal drug rifaximin, marketed as Xifaxan. Lupin recently granted Salix exclusive worldwide rights, outside India, to use that technology and any technology jointly developed by the companies for all rifaximin products for human use, according to MedCity News

[Read More]